Gene · 60675
Papers1,805
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,805
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting vascular normalization: a promising strategy to improve immune-vascular crosstalk in cancer immunotherapy. | Front Immunol | 2023 | 38193080 | PubTator, text mining | PubMed |
| Plasma cell-free RNA profiling of Vietnamese Alzheimer's patients reveals a linkage with chronic inflammation and apoptosis: a pilot study. | Front Mol Neurosci | 2023 | 38178908 | PubTator, text mining | PubMed |
| Dipeptidyl peptidase 1 inhibition as a potential therapeutic approach in neutrophil-mediated inflammatory disease. | Front Immunol | 2023 | 38162644 | PubTator, text mining | PubMed |
| Pheromone biosynthesis activating neuropeptide family in insects: a review. | Front Endocrinol (Lausanne) | 2023 | 38161974 | PubTator, text mining | PubMed |
| Environmental and Genetic Traffic in the Journey from Sperm to Offspring. | Biomolecules | 2023 | 38136630 | PubTator, text mining | PubMed |
| Cross-linking breast tumor transcriptomic states and tissue histology. | Cell Rep Med | 2023 | 38118424 | PubTator, text mining | PubMed |
| Interleukin-30 subverts prostate cancer-endothelium crosstalk by fostering angiogenesis and activating immunoregulatory and oncogenic signaling pathways. | J Exp Clin Cancer Res | 2023 | 38087324 | PubTator, text mining | PubMed |
| Adipose-Derived Stem Cells to Treat Ischemic Diseases: The Case of Peripheral Artery Disease. | Int J Mol Sci | 2023 | 38069074 | PubTator, text mining | PubMed |
| Prokineticin 2 is a catabolic regulator of osteoarthritic cartilage destruction in mouse. | Arthritis Res Ther | 2023 | 38057865 | PubTator, text mining | PubMed |
| Differences in gene expression profiles in early and late stage rhodesiense HAT individuals in Malawi. | PLoS Negl Trop Dis | 2023 | 38055777 | PubTator, text mining | PubMed |
| Role of long-chain polyunsaturated fatty acids, eicosapentaenoic and docosahexaenoic, in the regulation of gene expression during the development of obesity: a systematic review. | Front Nutr | 2023 | 38024342 | PubTator, text mining | PubMed |
| WT1 Dendritic Cell Vaccine Therapy Improves Immune Profile and Prolongs Progression-Free Survival in End-Stage Lung Cancer. | Cureus | 2023 | 38022278 | PubTator, text mining | PubMed |
| Analysis of prognostic germline polymorphisms in patients with advanced hepatocellular carcinoma. | Transl Gastroenterol Hepatol | 2023 | 38021355 | PubTator, text mining | PubMed |
| Exploiting innate immunity for cancer immunotherapy. | Mol Cancer | 2023 | 38008741 | PubTator, text mining | PubMed |
| Unwinding the SARS-CoV-2 Ribosomal Frameshifting Pseudoknot with LNA and G-Clamp-Modified Phosphorothioate Oligonucleotides Inhibits Viral Replication. | Biomolecules | 2023 | 38002341 | PubTator, text mining | PubMed |
| Good Cop, Bad Cop: Profiling the Immune Landscape in Multiple Myeloma. | Biomolecules | 2023 | 38002311 | PubTator, text mining | PubMed |
| The Prokineticin System in Inflammatory Bowel Diseases: A Clinical and Preclinical Overview. | Biomedicines | 2023 | 38001985 | PubTator, text mining | PubMed |
| Investigation of the molecular genetic causes of non-syndromic primary ovarian ınsufficiency by next generation sequencing analysis. | Arch Endocrinol Metab | 2023 | 37988663 | PubTator, text mining | PubMed |
| Protein kinase PfPK2 mediated signalling is critical for host erythrocyte invasion by malaria parasite. | PLoS Pathog | 2023 | 37988347 | PubTator, text mining | PubMed |
| Condensin positioning at telomeres by shelterin proteins drives sister-telomere disjunction in anaphase. | Elife | 2023 | 37988290 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/60675/papers?page=6